Anthony Polverino
Director/Miembro de la Junta en BRAINSTORM CELL THERAPEUTICS INC. .
Fortuna: 12 643 $ al 31/05/2024
Perfil
Dr. Anthony J.
Polverino is an Independent Director at Brainstorm Cell Therapeutics, Inc. He is on the Board of Directors at Brainstorm Cell Therapeutics, Inc. Dr. Polverino was previously employed as a Chief Scientific Officer & EVP-Early Development by Zymeworks BC, Inc., a Chief Scientific Officer by Kite Pharma, Inc., and an Executive Director-Therapeutic Innovation Unit by Amgen, Inc. He received his undergraduate degree from the University of Adelaide and a doctorate degree from Flinders University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/03/2024 | 25 960 ( 0.04% ) | 12 643 $ | 31/05/2024 |
Cargos activos de Anthony Polverino
| Empresas | Cargo | Inicio |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Director/Miembro de la Junta | 05/02/2018 |
Antiguos cargos conocidos de Anthony Polverino.
| Empresas | Cargo | Fin |
|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Director Técnico/Científico/I+D | 19/01/2022 |
| KITE PHARMA INC | Director Técnico/Científico/I+D | 01/01/2018 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formación de Anthony Polverino.
| University of Adelaide | Undergraduate Degree |
| Flinders University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Anthony Polverino
